{"entity":{"type":"insider","cik":"0001619961","url":"/insider/0001619961","json_url":"/insider/0001619961.json","name":"MORTIMER IAN","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":31,"n_filings":10,"first":"2016-06-28","last":"2026-03-13","span_basis":"filed_date"},"name_variants":[{"name":"MORTIMER IAN","source":"filing","n_filings":10,"first_seen":"2016-06-28","last_seen":"2026-03-13"}],"transactions":[{"id":5884240,"accession":"0001193125-26-106724","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-26-106724","line_url":"/filing/0001193125-26-106724#line-2","is_derivative":false,"issuer_cik":"0001582313","issuer_name":"Xenon Pharmaceuticals Inc.","issuer_ticker":"XENE","issuer_name_source":null,"issuer_url":"/issuer/0001582313","owner_cik":"0001619961","owner_name":"MORTIMER IAN","owner_display_name":"MORTIMER IAN","owner_url":"/insider/0001619961","role":"Director, Officer (PRESIDENT & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT & CEO","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7308.0,"shares_display":"7,308","price_per_share":55.225,"price_display":"55.22","price_state":"stated","total_value":403584.3,"total_display":"403,584.30","total_whole":"403,584","shares_owned_after":19923.0,"shares_owned_after_display":"19,923","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-13","filed_date":"2026-03-13","scope":"insider"},{"id":5836857,"accession":"0001193125-26-102666","txn_seq":15,"anchor":"line-15","filing_url":"/filing/0001193125-26-102666","line_url":"/filing/0001193125-26-102666#line-15","is_derivative":false,"issuer_cik":"0001582313","issuer_name":"Xenon Pharmaceuticals Inc.","issuer_ticker":"XENE","issuer_name_source":null,"issuer_url":"/issuer/0001582313","owner_cik":"0001619961","owner_name":"MORTIMER IAN","owner_display_name":"MORTIMER IAN","owner_url":"/insider/0001619961","role":"Director, Officer (PRESIDENT & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT & CEO","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11269.0,"shares_display":"11,269","price_per_share":60.108,"price_display":"60.11","price_state":"stated","total_value":677357.052,"total_display":"677,357.05","total_whole":"677,357","shares_owned_after":14731.0,"shares_owned_after_display":"14,731","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-10","filed_date":"2026-03-11","scope":"insider"},{"id":5836855,"accession":"0001193125-26-102666","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0001193125-26-102666","line_url":"/filing/0001193125-26-102666","is_derivative":false,"issuer_cik":"0001582313","issuer_name":"Xenon Pharmaceuticals Inc.","issuer_ticker":"XENE","issuer_name_source":null,"issuer_url":"/issuer/0001582313","owner_cik":"0001619961","owner_name":"MORTIMER IAN","owner_display_name":"MORTIMER IAN","owner_url":"/insider/0001619961","role":"Director, Officer (PRESIDENT & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT & CEO","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":270000.0,"shares_display":"270,000","price_per_share":60.330157407407405,"price_display":"60.33","price_state":"stated","total_value":16289142.5,"total_display":"16,289,142.50","total_whole":"16,289,143","shares_owned_after":6000.0,"shares_owned_after_display":"6,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-09","filed_date":"2026-03-11","scope":"insider","n_lines":9},{"id":5748639,"accession":"0001193125-26-001172","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001193125-26-001172","line_url":"/filing/0001193125-26-001172","is_derivative":false,"issuer_cik":"0001582313","issuer_name":"Xenon Pharmaceuticals Inc.","issuer_ticker":"XENE","issuer_name_source":null,"issuer_url":"/issuer/0001582313","owner_cik":"0001619961","owner_name":"MORTIMER IAN","owner_display_name":"MORTIMER IAN","owner_url":"/insider/0001619961","role":"Director, Officer (PRESIDENT & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT & CEO","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40000.0,"shares_display":"40,000","price_per_share":44.4273215,"price_display":"44.43","price_state":"stated","total_value":1777092.86,"total_display":"1,777,092.86","total_whole":"1,777,093","shares_owned_after":8062.0,"shares_owned_after_display":"8,062","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-02","filed_date":"2026-01-02","scope":"insider","n_lines":2},{"id":4344129,"accession":"0001193125-25-313147","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001193125-25-313147","line_url":"/filing/0001193125-25-313147","is_derivative":false,"issuer_cik":"0001582313","issuer_name":"Xenon Pharmaceuticals Inc.","issuer_ticker":"XENE","issuer_name_source":null,"issuer_url":"/issuer/0001582313","owner_cik":"0001619961","owner_name":"MORTIMER IAN","owner_display_name":"MORTIMER IAN","owner_url":"/insider/0001619961","role":"Director, Officer (PRESIDENT & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT & CEO","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10830.0,"shares_display":"10,830","price_per_share":45.725484764542934,"price_display":"45.73","price_state":"stated","total_value":495207.0,"total_display":"495,207.00","total_whole":"495,207","shares_owned_after":8010.0,"shares_owned_after_display":"8,010","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-08","filed_date":"2025-12-09","scope":"insider","n_lines":2},{"id":4344122,"accession":"0001193125-25-313147","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-25-313147","line_url":"/filing/0001193125-25-313147#line-1","is_derivative":false,"issuer_cik":"0001582313","issuer_name":"Xenon Pharmaceuticals Inc.","issuer_ticker":"XENE","issuer_name_source":null,"issuer_url":"/issuer/0001582313","owner_cik":"0001619961","owner_name":"MORTIMER IAN","owner_display_name":"MORTIMER IAN","owner_url":"/insider/0001619961","role":"Director, Officer (PRESIDENT & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT & CEO","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14375.0,"shares_display":"14,375","price_per_share":45.03,"price_display":"45.03","price_state":"stated","total_value":647306.25,"total_display":"647,306.25","total_whole":"647,306","shares_owned_after":16830.0,"shares_owned_after_display":"16,830","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-05","filed_date":"2025-12-09","scope":"insider"},{"id":4426491,"accession":"0001193125-25-307211","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-25-307211","line_url":"/filing/0001193125-25-307211#line-1","is_derivative":false,"issuer_cik":"0001582313","issuer_name":"Xenon Pharmaceuticals Inc.","issuer_ticker":"XENE","issuer_name_source":null,"issuer_url":"/issuer/0001582313","owner_cik":"0001619961","owner_name":"MORTIMER IAN","owner_display_name":"MORTIMER IAN","owner_url":"/insider/0001619961","role":"Director, Officer (PRESIDENT & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT & CEO","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":97.0,"shares_display":"97","price_per_share":45.01,"price_display":"45.01","price_state":"stated","total_value":4365.97,"total_display":"4,365.97","total_whole":"4,366","shares_owned_after":31205.0,"shares_owned_after_display":"31,205","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-28","filed_date":"2025-12-03","scope":"insider"},{"id":4031474,"accession":"0001193125-25-227202","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-25-227202","line_url":"/filing/0001193125-25-227202#line-2","is_derivative":false,"issuer_cik":"0001582313","issuer_name":"Xenon Pharmaceuticals Inc.","issuer_ticker":"XENE","issuer_name_source":null,"issuer_url":"/issuer/0001582313","owner_cik":"0001619961","owner_name":"MORTIMER IAN","owner_display_name":"MORTIMER IAN","owner_url":"/insider/0001619961","role":"Director, Officer (PRESIDENT, CEO & INTERIM CFO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT, CEO & INTERIM CFO","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":40.16,"price_display":"40.16","price_state":"stated","total_value":1004000.0,"total_display":"1,004,000.00","total_whole":"1,004,000","shares_owned_after":31302.0,"shares_owned_after_display":"31,302","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-01","filed_date":"2025-10-01","scope":"insider"},{"id":4163262,"accession":"0000950170-25-009388","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0000950170-25-009388","line_url":"/filing/0000950170-25-009388","is_derivative":false,"issuer_cik":"0001582313","issuer_name":"Xenon Pharmaceuticals Inc.","issuer_ticker":"XENE","issuer_name_source":null,"issuer_url":"/issuer/0001582313","owner_cik":"0001619961","owner_name":"MORTIMER IAN","owner_display_name":"MORTIMER IAN","owner_url":"/insider/0001619961","role":"Director, Officer (PRESIDENT & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT & CEO","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16315.0,"shares_display":"16,315","price_per_share":40.502959852896105,"price_display":"40.50","price_state":"stated","total_value":660805.79,"total_display":"660,805.79","total_whole":"660,806","shares_owned_after":31302.0,"shares_owned_after_display":"31,302","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-27","filed_date":"2025-01-27","scope":"insider","n_lines":2},{"id":4163246,"accession":"0000950170-25-009388","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000950170-25-009388","line_url":"/filing/0000950170-25-009388#line-4","is_derivative":false,"issuer_cik":"0001582313","issuer_name":"Xenon Pharmaceuticals Inc.","issuer_ticker":"XENE","issuer_name_source":null,"issuer_url":"/issuer/0001582313","owner_cik":"0001619961","owner_name":"MORTIMER IAN","owner_display_name":"MORTIMER IAN","owner_url":"/insider/0001619961","role":"Director, Officer (PRESIDENT & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT & CEO","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22468.0,"shares_display":"22,468","price_per_share":40.2,"price_display":"40.20","price_state":"stated","total_value":903213.6,"total_display":"903,213.60","total_whole":"903,214","shares_owned_after":31302.0,"shares_owned_after_display":"31,302","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-24","filed_date":"2025-01-27","scope":"insider"},{"id":4163240,"accession":"0000950170-25-009388","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-009388","line_url":"/filing/0000950170-25-009388#line-2","is_derivative":false,"issuer_cik":"0001582313","issuer_name":"Xenon Pharmaceuticals Inc.","issuer_ticker":"XENE","issuer_name_source":null,"issuer_url":"/issuer/0001582313","owner_cik":"0001619961","owner_name":"MORTIMER IAN","owner_display_name":"MORTIMER IAN","owner_url":"/insider/0001619961","role":"Director, Officer (PRESIDENT & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT & CEO","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16217.0,"shares_display":"16,217","price_per_share":40.08,"price_display":"40.08","price_state":"stated","total_value":649977.36,"total_display":"649,977.36","total_whole":"649,977","shares_owned_after":31302.0,"shares_owned_after_display":"31,302","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-23","filed_date":"2025-01-27","scope":"insider"},{"id":8749777,"accession":"0000950170-23-024600","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0000950170-23-024600","line_url":"/filing/0000950170-23-024600","is_derivative":false,"issuer_cik":"0001582313","issuer_name":"Xenon Pharmaceuticals Inc.","issuer_ticker":"XENE","issuer_name_source":null,"issuer_url":"/issuer/0001582313","owner_cik":"0001619961","owner_name":"MORTIMER IAN","owner_display_name":"MORTIMER IAN","owner_url":"/insider/0001619961","role":"Director, Officer (PRESIDENT & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT & CEO","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":31655.0,"shares_display":"31,655","price_per_share":41.41307913441794,"price_display":"41.41","price_state":"stated","total_value":1310931.02,"total_display":"1,310,931.02","total_whole":"1,310,931","shares_owned_after":24213.0,"shares_owned_after_display":"24,213","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-24","filed_date":"2023-05-26","scope":"insider","n_lines":3},{"id":4501076,"accession":"0001171843-17-005071","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001171843-17-005071","line_url":"/filing/0001171843-17-005071","is_derivative":false,"issuer_cik":"0001582313","issuer_name":"Xenon Pharmaceuticals Inc.","issuer_ticker":"XENE","issuer_name_source":null,"issuer_url":"/issuer/0001582313","owner_cik":"0001619961","owner_name":"MORTIMER IAN","owner_display_name":"MORTIMER IAN","owner_url":"/insider/0001619961","role":"Officer (CFO & COO)","role_mark":"O","role_mark_label":"Officer (CFO & COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO & COO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15000.0,"shares_display":"15,000","price_per_share":2.881666666666667,"price_display":"2.88","price_state":"stated","total_value":43225.0,"total_display":"43,225.00","total_whole":"43,225","shares_owned_after":14300.0,"shares_owned_after_display":"14,300","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-08-10","filed_date":"2017-08-14","scope":"insider","n_lines":2},{"id":2692336,"accession":"0001171843-16-010872","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001171843-16-010872","line_url":"/filing/0001171843-16-010872","is_derivative":false,"issuer_cik":"0001582313","issuer_name":"Xenon Pharmaceuticals Inc.","issuer_ticker":"XENE","issuer_name_source":null,"issuer_url":"/issuer/0001582313","owner_cik":"0001619961","owner_name":"MORTIMER IAN","owner_display_name":"MORTIMER IAN","owner_url":"/insider/0001619961","role":"Officer (CFO & COO)","role_mark":"O","role_mark_label":"Officer (CFO & COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO & COO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5300.0,"shares_display":"5,300","price_per_share":6.215094339622642,"price_display":"6.22","price_state":"stated","total_value":32940.0,"total_display":"32,940.00","total_whole":"32,940","shares_owned_after":3000.0,"shares_owned_after_display":"3,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-06-24","filed_date":"2016-06-28","scope":"insider","n_lines":4}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":31,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":6,"open_market":true},{"code":"S","label":"Open-market sale","n":25,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":31},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001582313","name":"Xenon Pharmaceuticals Inc.","url":"/issuer/0001582313","role":"Director, Officer (PRESIDENT & CEO)","n_filings":10,"first_seen":"2016-06-28","last_seen":"2026-03-13"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001619961","retrieved_at":"2026-08-25T02:27:45+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}